Abcuro
Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases
$66MSeries D
Role not disclosedFC
Foresite Capital
Activity from announced rounds
Activity in this selectionallina-health-258a8846
- Rounds participated in
- 7
- Confirmed lead rounds
- — 7 roles undisclosed
- New companies
- 7 First participation on record · 0 follow-on
- Funding in participating rounds
- $881M 7 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
7 in this selectionKhartis Therapeutics
Develops oral small molecule therapies for immunological and chronic diseases
$50MSeries B
Role not disclosedStepful
Offers accelerated, affordable training for healthcare careers
$55MSeries C
Role not disclosedSlate Medicines
Advancing next-generation therapeutics for migraine and other headache disorders
$130MSeries A
Role not disclosedKorsana Biosciences
Develops novel therapies to reduce the burden of neurodegenerative diseases
$175MSeries A
Role not disclosedMidi Health
Provides accessible, insurance-covered services in all 50 states for women's healthcare
$100MSeries D
Role not disclosedParabilis Medicines
Develops medicines targeting historically undruggable protein targets in cancer
$305MSeries F
Role not disclosed